Raykov Rosty's Form 4 filing
Fennec Pharmaceuticals Inc. (FENC) · filed Jun 3, 2024
- Accession no.
- 0001415889-24-015177
- Filed
- Jun 3, 2024
- Trade date
- May 31-Jun 3, 2024
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $16.4K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Raykov RostyCIK 0001468316 | Director, Officer (CHIEF EXECUTIVE OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 31, 2024 | Common shares | AGrant or awardAcquired | +2,431 | $0.00 | $0 | 189,902 | Direct | |
| Jun 3, 2024 | Common shares | SSaleDisposed | −2,431 | $6.76 | −$16,433.56 | 187,471 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.